NIH-funded research R01 grant

Targeting a brain inflammation regulator to protect cells after a stroke

Official title: Targeting Glial HuR to Suppress Inflammation and Promote Neuroprotection in Acute Stroke

Funded at University of Alabama at Birmingham · NIH-11380954 · Data updated 2026-11-12

Aims to test a new approach that tampers with a key brain cell regulator to reduce inflammation and protect brain tissue after a stroke, potentially lowering disability.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2030
Funding year2026
Award (this year)$540,236
NIH project number5R01NS141123-02
Project IDNIH-11380954 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults at risk of ischemic stroke or researchers studying stroke-related brain inflammation.

Less likely to help

Patients with non-stroke brain injuries or unrelated conditions may not benefit from this specific approach.

What this research studies

This project focuses on acute ischemic stroke, where inflammation worsens brain injury. Researchers will explore how blocking HuR, a regulator inside brain support cells, can dampen harmful inflammatory signals. The work involves laboratory studies that may translate to human patients in the future, aiming to preserve brain tissue and function after stroke. If successful, this could lead to new treatment strategies that complement current care.

Why it matters

Potential benefit: If successful, patients who have a stroke could experience less brain damage and better recovery.

How similar studies have gone: Other approaches targeting brain inflammation have shown promise, but this specific HuR-targeting strategy is novel.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: King, Peter H — University of Alabama at Birmingham
  • Study coordinator: King, Peter H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.